These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

283 related items for PubMed ID: 6173910

  • 1. [Current problems in the treatment of hepatic cirrhosis].
    Oancea R.
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1981; 33(4):303-10. PubMed ID: 6173910
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Practical problems in gout].
    Recordier AM.
    Mars Med; 1965; 102(5):407-16. PubMed ID: 5889111
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Long-term treatment of chronic hepatitis and liver cirrhosis].
    Pusch JH, Ullmann W.
    Med Klin; 1975 Apr 11; 70(15):674-81. PubMed ID: 806771
    [No Abstract] [Full Text] [Related]

  • 6. [Can alcohol damage of the liver be controlled by drugs?].
    Teschke R.
    Z Gastroenterol; 1987 May 11; 25(5):274-8. PubMed ID: 3617842
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Treatment of autoimmune chronic active hepatitis and of primary biliary cirrhosis].
    Renner EL.
    Schweiz Med Wochenschr; 1994 Mar 26; 124(12):495-501. PubMed ID: 8159985
    [Abstract] [Full Text] [Related]

  • 9. [Etiological treatment of cirrhosis in adults].
    Doffoël M, Gabanyi J, Vetter D.
    Rev Prat; 1997 Mar 01; 47(5):503-6. PubMed ID: 9138412
    [Abstract] [Full Text] [Related]

  • 10. [1 (+) ornithine alpha ketoglutarate in hepatic encephalopathy].
    Paris J, Merveille P, Molimard R.
    Presse Med (1893); 1970 Jun 20; 78(30):1367-8. PubMed ID: 5421555
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Clinical studies on the liver-protective effect of 4-amino-5-imidazole carboxamide and orotic acid].
    Fehér VJ, Jakab L, Tenczer J, Szilvási I.
    Dtsch Z Verdau Stoffwechselkr; 1977 Jun 20; 37(4):175-9. PubMed ID: 75788
    [No Abstract] [Full Text] [Related]

  • 14. [Inquiries on the etiology, pathogenesis, therapeutic successes and survival time in a random group of 560 patients with liver cirrhosis].
    Creutzfeldt W, Beck K.
    Dtsch Med Wochenschr; 1966 Apr 15; 91(15):682-9. PubMed ID: 5932096
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Controlled clinical evaluation of the therapeutic effectiveness of AICA orotate in chronic hepatitis].
    Roda E, Sama C, Festi D.
    Clin Ter; 1979 Jun 15; 89(5):489-93. PubMed ID: 535326
    [No Abstract] [Full Text] [Related]

  • 18. [Use of corticosteroids and anabolic steroids in the treatment of patients with liver cirrhosis].
    Markov MI, Piralov GV.
    Vrach Delo; 1972 Apr 15; 4():70-2. PubMed ID: 5048960
    [No Abstract] [Full Text] [Related]

  • 19. [What is safe in therapy of primary biliary cirrhosis?].
    Wiedmann KH, Weber P, Lauchart W.
    Internist (Berl); 1988 Nov 15; 29(11):765-77. PubMed ID: 3069789
    [No Abstract] [Full Text] [Related]

  • 20. [Hyperammoniemia and its treatment].
    Szám I.
    Orv Hetil; 1973 Oct 28; 114(43):2581-9. PubMed ID: 4585544
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.